[1] MICALE V, DRAGO F. Endocannabinoid system, stress and HPA axis[J]. Eur J Pharmacol, 2018, 834: 230-239. [2] BALAZS Z, SCHWEIZER R A, FREY F J, et al. DHEA induces 11 beta-HSD2 by acting on CCAAT/enhancer-binding proteins[J]. J Am Soc Nephrol, 2008, 19(1): 92-101. [3] APOSTOLOVA G, SCHWEIZER R A S, BALAZS Z, et al. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue[J]. Am J Physiol-Endocrinol Metabol, 2005, 288(5): E957-E964. [4] BRADSHAW H B, WALKER J M. The expanding field of cannabimimetic and related lipid mediators[J]. Br J Pharmacol, 2005, 144(4): 459-465. [5] KRUMBHOLZ A, ANIELSKI P, REISCH N, et al. Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair[J]. Ther Drug Monit, 2013, 35(5): 600-607. [6] GAO W, WALTHER A, WEKENBORG M, et al. Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety[J]. Talanta, 2020, 217: 121006. [7] QIAO S, LI X M, ZILIOLI S, et al. Hair measurements of cortisol, DHEA, and DHEA to cortisol ratio as biomarkers of chronic stress among people living with HIV in China: known-group validation[J]. PloS One, 2017, 12(1): e169827. [8] DÓCS K, MÉSZÁR Z, GONDA S, et al. The ratio of 2-AG to Its Isomer 1-AG as an intrinsic fine tuning mechanism of CB1 receptor activation[J]. Front Cell Neurosci, 2017, 11: 39. [9] ZAPANTI E, TERZIDIS K, CHROUSOS G. Dysfunction of the hypothalamic-pituitary-adrenal axis in HIV infection and disease[J]. Horm-Int J Endocrino, 2008, 7(3): 205-216. [10] CHROUSOS G P, ZAPANTI E D. Hypothalamic-pituitary-adrenal axis in HIV infection and disease[J]. Endocrin Metab Clin, 2014, 43(3): 791-806. [11] VILLETTE J M, BOURIN P, DOINEL C, et al. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus[J]. J Clin Endocrinol Metab, 1990, 70(3): 572-577. [12] CHRISTEFF N, MELCHIOR J C, DE TRUCHIS P, et al. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations[J]. AIDS, 1999, 13(16): 2251-2260. [13] CHRISTEFF N, GHERBI N, MAMMES O, et al. Serum cortisol and DHEA concentrations during HIV infection[J]. Psychoneuroendocrino, 1997, 221: S11-S18. [14] LANGERAK T, VAN DEN DRIES L W, WESTER V L, et al. The relation between long-term cortisol levels and the metabolic syndrome in HIV-infected patients[J]. Clin Endocrinol, 2015, 83(2): 167-172. [15] MARIK P E, KIMINYO K, ZALOGA G P. Adrenal insufficiency in critically ill patients with human immunodeficiency virus[J]. Crit Care Med, 2002, 30(6): 1267-1273. [16] HILL M N, PATEL S, CAMPOLONGO P, et al. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output[J]. J Neurosci, 2010, 30(45): 14980-14986. [17] PATEL S, KINGSLEY P J, MACKIE K, et al. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala[J]. Neuropsychopharmacol, 2009, 34(13): 2699-2709. [18] HILL M N, MCLAUGHLIN R J, BINGHAM B, et al. Endogenous cannabinoid signaling is essential for stress adaptation[J]. Proc Natl Acad Sci USA, 2010, 107(20): 9406-9411. [19] PRAGST F, BALIKOVA M A. State of the art in hair analysis for detection of drug and alcohol abuse[J]. Clin Chim Acta, 2006, 370(1/2): 17-49. [20] GILL J, VYTHILINGAM M, PAGE G G.Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD[J]. J Traum Stress, 2008, 21(6): 530-539. [21] WILKER S, PFEIFFER A, ELBERT T, et al. Endocannabinoid concentrations in hair are associated with PTSD symptom severity[J]. Psychoneuroendocrino, 2016, 67: 198-206. |